Healthcare
Healthcare
First Combined Heart Pump and Pig Kidney Transplant
NYU Langone Health Surgeons Achieve Medical Milestone with World’s First Combined Heart Pump and Pig Kidney Transplant Surgeons at NYU Langone Health have...
FDA: Bird Flu Residue Found in U.S. Milk, Supply Safe
The Food and Drug Administration (FDA) made a concerning announcement on Tuesday, revealing that samples of pasteurized milk from various regions across the...
WHO Warns of Increasing Risk of Bird Flu Spreading to Humans
A senior World Health Organization (WHO) official has issued a stark warning about the increasing risk of human-to-human transmission of bird flu. Despite...
Cancer Treatment’s New Hope: Checkpoint Inhibitors
Two decades ago, patients with aggressive cancers faced grim prognoses, as treatment options were limited. However, a paradigm shift occurred with the introduction...
Eli Lilly’s Zepbound Reduces Sleep Apnea in Obese Adults
Eli Lilly’s Zepbound, a weight loss drug, showed promise in treating sleep apnea in obese adults, the company announced Wednesday. Results from late-stage...
Supreme Court OKs Idaho’s Ban on Youth Gender-Affirming Care
The Supreme Court’s decision to allow Idaho to enforce its ban on gender-affirming care for minors, pending appeal, marks a significant development in...
Single-Shot Vaccine Protects Infants Against COVID and Flu: Study
A breakthrough in vaccine development could revolutionize infant immunization, offering prolonged protection against diseases like COVID-19 and the flu with just a single...
Study: Ozempic, Wegovy Not Linked to Higher Thyroid Cancer Risk
A comprehensive study recently conducted has shed new light on the potential correlation between GLP-1 medications like Ozempic and Wegovy and the risk...
Prostate Cancer Cases to Double by 2040, Study Finds
A recent study published in The Lancet medical journal has projected a substantial increase in global prostate cancer cases and deaths by the...
ALS Drug Relyvrio Withdrawn Due to Ineffectiveness
Amylyx Pharmaceuticals has decided to withdraw its ALS drug Relyvrio from the market following disappointing results from a phase III trial. The drug,...
